• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性硬化症患者室管膜下巨细胞肿瘤的患病率及文献综述。

Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature.

作者信息

Adriaensen M E A P M, Schaefer-Prokop C M, Stijnen T, Duyndam D A C, Zonnenberg B A, Prokop M

机构信息

Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Eur J Neurol. 2009 Jun;16(6):691-6. doi: 10.1111/j.1468-1331.2009.02567.x. Epub 2009 Feb 19.

DOI:10.1111/j.1468-1331.2009.02567.x
PMID:19236458
Abstract

BACKGROUND AND PURPOSE

To investigate the prevalence of subependymal giant cell ependymomas (SEGA) in patients with tuberous sclerosis complex (TSC).

METHODS

We performed a retrospective cross-sectional study in a cohort of 285 patients with known TSC. Institutional review board approval was obtained. We included all 214 TSC-patients who had received a contrast-enhanced computed tomography (CT) scan of the brain. The most recent scan was evaluated for SEGA and presence of hydrocephalus. Additionally, a literature search was performed, and pooled estimates of SEGA prevalence in TSC were calculated. We used descriptive statistics, two sample t-test, chi-squared-test, and meta-analysis as appropriate.

RESULTS

Computed tomography showed radiological evidence of SEGA in 43 of the 214 TSC-patients (20%); 23 of 105 men (22%) and 20 of 109 women (18%; P = .52). Average maximum tumor size was 11.4 mm (range, 4-29 mm). Patients with SEGA (mean, 31 years; range, 16-58 years) were on average younger than patients without SEGA (mean, 37 years; range, 10-72 years; P = 0.007). No association between tumor size and patient age was detected. Nine patients had bilateral SEGA. Hydrocephalus was present in six of the 43 patients (14%). Meta-analysis of reported prevalence and our current study showed that studies using radiological evidence to diagnose SEGA gave a higher pooled estimate of the prevalence of SEGA in TSC (0.16; 95% CI: 0.12, 0.21) than studies using mainly histopathological evidence of SEGA (0.09; 95% CI: 0.07, 0.12).

CONCLUSIONS

In our cohort, CT demonstrated evidence of SEGA in 20% of TSC-patients. Prevalence of SEGA in TSC is higher in studies using radiological evidence to diagnose SEGA than in studies using histopathological evidence.

摘要

背景与目的

研究结节性硬化症(TSC)患者室管膜下巨细胞型室管膜瘤(SEGA)的患病率。

方法

我们对285例已知患有TSC的患者进行了一项回顾性横断面研究。获得了机构审查委员会的批准。我们纳入了所有214例接受过脑部增强计算机断层扫描(CT)的TSC患者。对最近的扫描结果进行SEGA及脑积水情况评估。此外,进行了文献检索,并计算了TSC中SEGA患病率的汇总估计值。我们酌情使用了描述性统计、两样本t检验、卡方检验和荟萃分析。

结果

CT显示214例TSC患者中有43例(20%)有SEGA的影像学证据;105名男性中有23例(22%),109名女性中有20例(18%;P = 0.52)。肿瘤平均最大尺寸为11.4毫米(范围4 - 29毫米)。患有SEGA的患者(平均年龄31岁;范围16 - 58岁)平均比未患SEGA的患者年轻(平均年龄37岁;范围10 - 72岁;P = 0.007)。未检测到肿瘤大小与患者年龄之间的关联。9例患者有双侧SEGA。43例患者中有6例(14%)存在脑积水。对已报道的患病率与我们当前研究进行的荟萃分析表明,与主要使用SEGA组织病理学证据的研究(0.09;95%置信区间:0.07,0.12)相比,使用影像学证据诊断SEGA时,TSC中SEGA患病率的汇总估计值更高(0.16;95%置信区间:0.12,0.21)。

结论

在我们的队列中,CT显示20%的TSC患者有SEGA的证据。与使用组织病理学证据的研究相比,使用影像学证据诊断SEGA时,TSC中SEGA的患病率更高。

相似文献

1
Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature.结节性硬化症患者室管膜下巨细胞肿瘤的患病率及文献综述。
Eur J Neurol. 2009 Jun;16(6):691-6. doi: 10.1111/j.1468-1331.2009.02567.x. Epub 2009 Feb 19.
2
Natural history and CT scan follow-up of subependymal giant cell tumors in tuberous sclerosis complex patients.结节性硬化症患者室管膜下巨细胞肿瘤的自然病史和 CT 扫描随访。
J Clin Neurosci. 2014 Jun;21(6):939-41. doi: 10.1016/j.jocn.2013.08.022. Epub 2013 Nov 5.
3
Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.结节性硬化症患者室管膜下巨细胞星形细胞瘤生长速率与年龄的关系
Childs Nerv Syst. 2016 Jan;32(1):89-95. doi: 10.1007/s00381-015-2947-4. Epub 2015 Nov 9.
4
Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis.SEGA 相关结节性硬化症患者行室管膜下巨细胞星形细胞瘤切除术的结局:一项全国性索赔数据库分析。
Curr Med Res Opin. 2012 Apr;28(4):657-63. doi: 10.1185/03007995.2012.658907. Epub 2012 Feb 29.
5
The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: a review.结节性硬化症患者室管膜下巨细胞星形细胞瘤的自然史:综述。
Rev Neurosci. 2018 Mar 28;29(3):295-301. doi: 10.1515/revneuro-2017-0027.
6
Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.结节性硬化症患者皮质结节内室管膜下巨细胞星形细胞瘤的独特发现:组织病理学评估
Childs Nerv Syst. 2017 Apr;33(4):601-607. doi: 10.1007/s00381-017-3335-z. Epub 2017 Jan 10.
7
Surgical resection of subependymal giant cell astrocytomas (SEGAs) and changes in SEGA-related conditions: a US national claims database study.室管膜下巨细胞星形细胞瘤(SEGAs)的手术切除与 SEGA 相关情况的变化:一项美国国家索赔数据库研究。
Curr Med Res Opin. 2012 Apr;28(4):651-6. doi: 10.1185/03007995.2012.658908. Epub 2012 Feb 29.
8
Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.无临床结节性硬化症情况下的孤立性室管膜下巨细胞星形细胞瘤(SEGA):两例报告及文献综述
Childs Nerv Syst. 2024 Jan;40(1):73-78. doi: 10.1007/s00381-023-06105-w. Epub 2023 Sep 2.
9
Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).结节性硬化症(TSC)相关室管膜下巨细胞星形细胞瘤(SEGA)中mTor抑制的剂量水平反应率。
Pediatr Blood Cancer. 2015 Oct;62(10):1754-60. doi: 10.1002/pbc.25573. Epub 2015 Apr 30.
10
The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).mTOR 抑制对结节性硬化症相关室管膜下巨细胞星形细胞瘤(SEGA)患者梗阻性脑积水的影响。
J Neurooncol. 2020 May;147(3):731-736. doi: 10.1007/s11060-020-03487-8. Epub 2020 Apr 13.

引用本文的文献

1
A bitopic mTORC inhibitor reverses phenotypes in a tuberous sclerosis complex model.一种双位点mTORC抑制剂可逆转结节性硬化症复合体模型中的表型。
Sci Rep. 2025 Jul 1;15(1):20367. doi: 10.1038/s41598-025-08345-z.
2
Surgical treatment of subependymal giant cell astrocytoma in patients with tuberous sclerosis complex-an institutional experience and results.结节性硬化症患者室管膜下巨细胞星形细胞瘤的外科治疗——机构经验与结果
Childs Nerv Syst. 2025 Mar 4;41(1):126. doi: 10.1007/s00381-025-06779-4.
3
Central nervous system manifestations of tuberous sclerosis complex: A single centre experience in Qatar.
结节性硬化症的中枢神经系统表现:卡塔尔的单一中心经验。
Saudi Med J. 2024 Nov;45(11):1245-1252. doi: 10.15537/smj.2024.45.11.20240444.
4
Therapeutic Approaches to Tuberous Sclerosis Complex: From Available Therapies to Promising Drug Targets.《结节性硬化症的治疗方法:从现有疗法到有前途的药物靶点》。
Biomolecules. 2024 Sep 21;14(9):1190. doi: 10.3390/biom14091190.
5
Radiotherapy for subependymal giant cell astrocytoma: time to challenge a historical ban? A case report and review of the literature.室管膜下巨细胞星形细胞瘤的放射治疗:是时候挑战历史禁令了吗?一例病例报告及文献复习。
J Med Case Rep. 2024 Jul 20;18(1):330. doi: 10.1186/s13256-024-04649-2.
6
Neoadjuvant Therapy with Everolimus for Subependymal Giant Cell Astrocytoma: A Case Report.依维莫司用于室管膜下巨细胞星形细胞瘤的新辅助治疗:一例报告
NMC Case Rep J. 2023 Oct 14;10:291-297. doi: 10.2176/jns-nmc.2022-0375. eCollection 2023.
7
Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.无临床结节性硬化症情况下的孤立性室管膜下巨细胞星形细胞瘤(SEGA):两例报告及文献综述
Childs Nerv Syst. 2024 Jan;40(1):73-78. doi: 10.1007/s00381-023-06105-w. Epub 2023 Sep 2.
8
Ocular manifestations of renal ciliopathies.肾脏纤毛病的眼部表现。
Pediatr Nephrol. 2024 May;39(5):1327-1346. doi: 10.1007/s00467-023-06096-5. Epub 2023 Aug 30.
9
Benign Glioma.良性脑胶质瘤。
Adv Exp Med Biol. 2023;1405:31-71. doi: 10.1007/978-3-031-23705-8_2.
10
Subependymal Giant Cell Astrocytoma Non-Associated With Tuberous Sclerosis Complex and Expression of OCT-4 and INI-1: A Case Report.与结节性硬化症无关的室管膜下巨细胞星形细胞瘤及OCT-4和INI-1的表达:一例报告
Cureus. 2023 May 18;15(5):e39187. doi: 10.7759/cureus.39187. eCollection 2023 May.